Oximes (i.e., C=n-o-) Patents (Class 514/640)
-
Patent number: 6316469Abstract: Selective serotonin reuptake inhibitors useful in the treatment of non-cardiac chest pain or the treatment of symptoms of gastro-esophageal reflux disease.Type: GrantFiled: March 1, 2000Date of Patent: November 13, 2001Assignee: Duke UniversityInventors: Krishnaswamy Ranga Krishnan, Christopher O'Connor, Indira Varia
-
Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
Patent number: 6297260Abstract: The present invention describes novel nitrosated and/or nitrosylated nonsteroidal antiinflammatory compounds, and novel compositions comprising at least one nitrosated and/or nitrosylated nonsteroidal antiinflammatory compound, and, optionally, at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase. The present invention also provides methods for treating, preventing and/or reducing inflammation, pain, and fever; decreasing or reversing the gastrointestinal, renal and other toxicities resulting from the use of nonsteroidal antiinflammatory drugs; treating and/or preventing gastrointestinal disorders; treating inflammatory disease states and disorders; and treating and/or preventing ophthalmic diseases or disorders.Type: GrantFiled: October 29, 1999Date of Patent: October 2, 2001Assignee: NitroMed, Inc.Inventors: Upul K. Bandarage, Qing Dong, Xinqin Fang, David S. Garvey, Gregory J. Mercer, Stewart K. Richardson, Joseph D. Schroeder, Tiansheng Wang -
Patent number: 6288071Abstract: Pesticidally active cyclohexadienyl derivative compounds of the formula I that are esters, oximes or amides are claimed. These compounds may be used as fungicides, acaricides and insecticides in plant protection.Type: GrantFiled: December 10, 1998Date of Patent: September 11, 2001Assignee: Bayer AktiengesellschaftInventors: Henry Szczepanski, Martin Zeller, Ottmar Franz Hüter
-
Patent number: 6274570Abstract: A liquid pesticidal composition, which is substantially free of water, comprising a hydrophobic pesticide or mixture of pesticides dissolved in an organic solvent and comprising as surfactants (a) a castor oil ethoxylate having 30-50 mol ethoxylate, (b) a branched C8-C18 alcohol ethoxylate having 5-10 mol ethoxylate, and (c) a tristyrenephenol-ethoxylate having 8-30 mol ethoxylate, or its phosphate or salt thereof. The compositions also include gels having a viscosity of 500 to 20,000 mPas and comprising additionally a gelling agent.Type: GrantFiled: December 22, 1998Date of Patent: August 14, 2001Assignee: Syngenta Crop Protection, Inc.Inventors: Manfred Vogt, William Baettig
-
Patent number: 6258852Abstract: Disclosed are methods for treating or preventing inflammatory bowel disease (IBD) using aryl nitrone compounds. Pharmaceutical compositions containing aryl nitrone compounds which are useful for the treatment or prophylaxis of IBD are also disclosed.Type: GrantFiled: May 8, 2000Date of Patent: July 10, 2001Assignee: Centaur Pharmaceuticals, Inc.Inventors: William D. Flitter, William A. Garland, Beverly Greenwood Van-Meerveld, Ian Irwin
-
Patent number: 6255352Abstract: A method for control of harmful fungi is provided by treating the fungi, or the materials, plants, the soil or seeds to be protected against fungal infection, with an effective amount of a bisoxime of the formula I or a salt or adduct thereof, the index and the substituents having the following meanings: R1 is halogen, alkyl or haloalkyl; R2 is cyano, nitro, halogen, alkyl, haloalkyl, alkoxy, haloalkoxy, alkylthio, alkylamino, dialkylamino, alkylaminocarbonyl, substituted or unsubstituted phenyl, phenoxy or phenylthio; n is 0, 1, 2 or 3; R3 is alkyl, haloalkyl, alkenyl, haloalkenyl, alkynyl, haloalkynyl or phenylalkyl.Type: GrantFiled: November 17, 1999Date of Patent: July 3, 2001Assignee: BASF AktiengesellschaftInventors: Wassilios Grammenos, Ruth Müller, Hubert Sauter, Herbert Bayer, Thomas Grote, Andreas Gypser, Reinhard Kirstgen, Bernd Müller, Arne Ptock, Franz Röhl, Gisela Lorenz, Eberhard Ammermann, Siegfried Strathmann
-
Patent number: 6251949Abstract: Compounds having fungicidal activities and represented by general formula (I) and salts and hydrates thereof wherein R1 represents an optionally substituted aryl, an optionally substituted alkyl or the like; R2 represents an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted aryl, an optionally substituted heterocyclic group or the like; R3 represents an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted arylsulfonyl, an optionally substituted heterocyclic group or the like; R4 and R5, which may be the same or different, represent each a hydrogen atom, an optionally substituted alkyl, or an optionally substituted alkoxy, or R4 and R5 may form together with the adjacent nitrogen atom an optionally substituted monocycle or polycycle; X and Y, which may be the same or different, represents each an oxygen atom or NR6 wherein R6 represents a hydrogeType: GrantFiled: December 9, 1999Date of Patent: June 26, 2001Assignee: Shionogi & Co., Ltd.Inventors: Moriyasu Masui, Norihiko Tanimoto, Kuniyoshi Nishida
-
Patent number: 6245782Abstract: The present invention pertains to methods for reducing the platelet activation state in an individual comprising administering a selective serotonin reuptake inhibitor (SSRI). The platelet activation state is reduced upon administering a SSRI, as measured by one or more platelet activation markers. The invention also relates to methods for treating or preventing an individual at risk for a vascular event, disease or disorder by administering a SSRI.Type: GrantFiled: May 17, 1999Date of Patent: June 12, 2001Assignee: Heartdrug Research L.L.C.Inventors: Victor L. Serebruany, Paul A. Gurbel, Christopher M. O'Connor
-
Patent number: 6235790Abstract: Hydroxamic acid derivatives of the general formula (I), in which Z, G, Ar, E, A1 and A have the meanings given in the description, to a process for their preparation, and to their use as pesticides, particularly as fungicides.Type: GrantFiled: July 20, 1999Date of Patent: May 22, 2001Assignee: Bayer AktiengesellschaftInventors: Bernd-Wieland Krüger, Lutz Assmann, Herbert Gayer, Peter Gerdes, Ulrich Heinemann, Dietmar Kuhnt, Thomas Seitz, Bernd Gallenkamp, Ral Tiemann, Gerd Hänssler, Heinz-Wilhelm Dehne, Stefan Dutzmann
-
Patent number: 6228350Abstract: The use, in a topical cosmetic composition, or for the manufacture of a topical dermatological composition, intended for depigmenting and/or bleaching human skin, body hair or head hair, of at least one compound comprising a phenyloxime fragment.Type: GrantFiled: January 24, 2000Date of Patent: May 8, 2001Assignee: L'OrealInventors: Remy Tuloup, Michel Philippe
-
Patent number: 6225353Abstract: A composition and method of preventing or inhibiting tumor growth, and of treating malignant melanoma, without toxic side effects are disclosed. Betulinic acid or a betulinic acid derivative is the active compound of the composition, which is topically applied to the situs of tumor.Type: GrantFiled: November 10, 1998Date of Patent: May 1, 2001Assignee: The Board of Trustees of the University of IllinoisInventors: John M. Pezzuto, Tapas K. DasGupta, Darrick S. H. L. Kim
-
Patent number: 6207716Abstract: Novel non-steroidal ligands for the estrogen receptor which possess tissue-dependent estrogenic and antiestrogenic activity as well as methods for making the same and their applications in treating a variety of disease states.Type: GrantFiled: October 30, 1998Date of Patent: March 27, 2001Assignee: Glaxo Wellcome Inc.Inventor: Timothy Mark Willson
-
Patent number: 6197825Abstract: The present invention relates to chromotropic nitrone spin trapping agents, methods of making these agents, compositions comprising same, and methods of their use. In particular, azulenyl nitrones of the present invention are effective agents for trapping free radical species and find use as efficient antioxidants in physicochemical and biological systems. Accordingly, the invention also relates to spin adducts formed from the combination of azulenyl nitrones with free radicals. The compounds of the present invention are readily prepared from available starting materials and find further use in assays and in a number of diagnostic, prophylactic and therapeutic applications, including but not limited to the alleviation, modulation and inhibition of the negative effects of carbon-centered or oxygen-centered radical species and other products of oxidation. Moreover, the combination adducts may be calorimetrically detected and, optionally, isolated and characterized to obtain valuable information (e.g.Type: GrantFiled: May 28, 1998Date of Patent: March 6, 2001Assignee: Florida International UniversityInventor: David Alan Becker
-
Patent number: 6197826Abstract: Disclosed are novel &agr;-(2-hydroxyphenyl) nitrone compounds and pharmaceutical compositions containing such compounds. The disclosed compositions are useful as therapeutics for inflammation-related conditions in mammals, such as arthritis, and as analytical reagents for detecting free radicals.Type: GrantFiled: July 16, 1999Date of Patent: March 6, 2001Assignee: Centaur Pharmaceuticals, Inc.Inventors: L. David Waterbury, John M. Carney, Allan L. Wilcox
-
Patent number: 6194461Abstract: A compound represented by the figure (1) or a pharmaceutically acceptable salt thereof is useful as medicament for treating retinal degenerative disorders: wherein Ar is optionally substitued phenyl or optionally substituted heteroaryl;. n is 0, 1 or 2; W is —CH2NH— or —CH═N(O)—; R1, R2 and R3 are independently optionally substituted alkyl, carboxyl or alkoxycarbonyl; any two groups of R1, R2 and R3 may be taken together with the carbon atom to form optionally substituted cycloalkane; all of R1, R2 and R3 may be taken together with the adjusent carbon atom to form optionally substituted bicycloalkane or optionally substituted tricycloalkane; R4 and R5 are independently hydrogen atom or optionally substituted alkyl.Type: GrantFiled: March 15, 1999Date of Patent: February 27, 2001Assignee: Sumitomo Pharmaceuticals Co., Ltd.Inventors: Kazuhito Ikeda, Tohru Tatsuno, Hiroki Ogo, Shuji Masumoto, Tatsuya Fujibayashi, Ryu Nagata
-
Patent number: 6191133Abstract: It has been found that the treatment of depression using known serotonin reuptake inhibitors (SRIs) and noradrenaline reuptake inhibitors (NRIs) may be improved by the administration therewith of folic acid or a precursor which produces folate in the patient. The daily dose of NRI or SRI is as prescribed for treatment of depression in the usual way. The daily dose of the folic acid or precursor should be such as to provide a folate dosage of 300-5000 micrograms/day.Type: GrantFiled: June 24, 1998Date of Patent: February 20, 2001Assignee: Scarista LimitedInventor: Alec James Coppen
-
Patent number: 6187808Abstract: This invention provides 6-amino-3,4,5,6,7,8-hexahydro-2H-naphthalen-1-one oximes and hydrazones which are useful in treating Parkinson's disease.Type: GrantFiled: September 27, 1999Date of Patent: February 13, 2001Assignee: Warner-Lambert CompanyInventors: Stephen Joseph Johnson, Leonard Theodore Meltzer, Lawrence David Wise
-
Patent number: 6166032Abstract: A method for controlling tobacco use and alleviating withdrawal symptoms due to the cessation of tobacco use comprising administering to a human desiring to control tobacco use and/or suffering from withdrawal due to cessation of such use an effective amount of an acetylcholine esterase reactivator or prodrug derivative thereof optionally in association with an acetylcholine receptor antagonist.Type: GrantFiled: February 7, 1997Date of Patent: December 26, 2000Assignee: Synapse Pharmaceuticals International, Inc.Inventor: Norman Viner
-
Patent number: 6147072Abstract: The invention relates to a method of treating psychosis, acute mania, mild anxiety states or depression in combination with psychotic episodes by administering to a patient a combination of an atypical antipsychotic and a serotonin reuptake inhibitor.Type: GrantFiled: September 23, 1997Date of Patent: November 14, 2000Assignee: Eli Lilly and CompanyInventors: Franklin P. Bymaster, Kenneth W. Perry, Gary D. Tollefson
-
Patent number: 6143792Abstract: The invention relates to the use of a specific 5HT2 receptor antagonist for the preparation of medicines useful in the treatment of the sleep apnea syndrome.Type: GrantFiled: March 27, 2000Date of Patent: November 7, 2000Assignee: Sanofi-SynthelaboInventor: Fran.cedilla.oise Cattelin
-
Patent number: 6140362Abstract: A method for inhibiting mammalian cell growth is disclosed. The method uses compounds known as N-acetonylarylamides. The compounds have been shown to inhibit cell mitosis and to inhibit microtubule assembly. The method may be used to treat diseases associated with rapid cell growth, particularly cancer. The compounds used in the method of the present invention may be used in combination with other therapies and may be administered by known techniques for drug administration.Type: GrantFiled: September 29, 1997Date of Patent: October 31, 2000Assignee: Rohm and Haas CompanyInventors: Enrique Luis Michelotti, David Hamilton Young
-
Patent number: 6140356Abstract: Ophthalmic pharmaceutical compositions containing a pharmaceutically acceptable ophthalmic carrier and an inflammation-treating amount of a nitrone compound are disclosed. Also disclosed are methods for treating ocular inflammation conditions, such as uveitis, using pharmaceutical compositions.Type: GrantFiled: September 20, 1999Date of Patent: October 31, 2000Assignee: Centaur Pharmaceuticals, Inc.Inventors: Kenneth W. Narducy, Efraim Duzman, John Michael Carney, Allan Lee Wilcox
-
Patent number: 6127407Abstract: The present invention provides substituted 3,3-diphenyl indanone, indane and indole compounds, as well as analogues thereof, which are specific, potent and safe inhibitors of mammalian cell proliferation. The compounds can be used to inhibit mammalian cell proliferation in situ as a therapeutic approach towards the treatment or prevention of diseases characterized by abnormal cell proliferation, such as cancer.Type: GrantFiled: November 20, 1997Date of Patent: October 3, 2000Assignees: Ion Pharmaceuticals, Inc., President and Fellows of Harvard College, Children's Medical Center CorporationInventors: Carlo Brugnara, Jose Halperin, Rudolf Fluckiger, Emile M. Bellott, Jr., Richard John Lombardy, John J. Clifford, Ying-Duo Gao, Reem M. Haidar, Eugene W. Kelleher, Adel M. Moussa, Yesh P. Sachdeva, Minghua Sun, Heather N. Taft
-
Patent number: 6083989Abstract: Disclosed are methods for treating or preventing inflammatory bowel disease (IBD) using aryl nitrone compounds. Pharmaceutical compositions containing aryl nitrone compounds which are useful for the treatment or prophylaxis of IBD are also disclosed.Type: GrantFiled: May 18, 1999Date of Patent: July 4, 2000Assignee: Centaur Pharmaceuticals, Inc.Inventors: William D. Flitter, William A. Garland, Beverly Greenwood Van-Meerveld, Ian Irwin
-
Patent number: 6083988Abstract: The present invention relates to chromotropic nitrone spin trapping agents, methods of making these agents, compositions comprising same, and methods of their use. In particular, azulenyl nitrones of the present invention are effective agents for trapping free radical species and find use as efficient antioxidants in physicochemical and biological systems. Accordingly, the invention also relates to spin adducts formed from the combination of azulenyl nitrones with free radicals. The compounds of the present invention are readily prepared from available starting materials and find further use in assays and in a number of diagnostic, prophylactic and therapeutic applications, including but not limited to the alleviation, modulation and inhibition of the negative effects of carbon-centered or oxygen-centered radical species and other products of oxidation. Moreover, the combination adducts may be calorimetrically detected and, optionally, isolated and characterized to obtain valuable information (e.g.Type: GrantFiled: September 4, 1997Date of Patent: July 4, 2000Inventor: David Alan Becker
-
Patent number: 6075023Abstract: Fish mycoses and single-cell ectoparasites on fish are controlled using an active compound suitable for inhibiting the mitochondrial respiratory chain at the stage of the b/c.sub.1 complex.Type: GrantFiled: February 17, 1998Date of Patent: June 13, 2000Assignee: BASF AktiengesellschaftInventors: Gerhard Peter Dohmen, Christoph Kunast, Reinhart Munk, Gerhard Rothhaas
-
Patent number: 6074634Abstract: The present invention provides an composition for attracting noctuid and/or other lepidopteran species. Liquid and solid formulations are provided, along with methods for their use, for controlling or eliminating noctuid and/or other lepidopteran species, and/or protecting plants susceptible to noctuid and/or other lepidopteran species damage.Type: GrantFiled: October 5, 1998Date of Patent: June 13, 2000Assignee: The United States of America as represented by the Secretary of AgricultureInventors: Juan D. Lopez, Jr., Ted N. Shaver, Kenneth R. Beerwinkle, Peter D. Lingren
-
Patent number: 6046232Abstract: Disclosed are novel .alpha.-aryl-N-alkylnitrone compounds and pharmaceutical compositions containing such compounds. The disclosed compositions are useful as therapeutics for preventing and/or treating neurodegenerative, autoimmune and inflammatory conditions in mammals and as analytical reagents for detecting free radicals.Type: GrantFiled: October 15, 1998Date of Patent: April 4, 2000Assignee: Centaur Pharmaceuticals, Inc.Inventors: Judith A. Kelleher, Kirk R. Maples, Alina Dykman, Yong-Kang Zhang, Allan L. Wilcox, Julian Levell
-
Patent number: 6043272Abstract: The present invention provides substituted 3,3-diphenyl indanone, indane and indole compounds, as well as analogues thereof, which are specific, potent and safe inhibitors of mammalian cell proliferation. The compounds can be used to inhibit mammalian cell proliferation in situ as a therapeutic approach towards the treatment or prevention of diseases characterized by abnormal cell proliferation, such as cancer.Type: GrantFiled: November 20, 1997Date of Patent: March 28, 2000Assignees: Ion Pharmaceuticals, Inc., President and Fellows of Harvard College, Children's Medical Center CorporationInventors: Carlo Brugnara, Jose Halperin, Rudolf Fluckiger, Emile M. Bellott, Jr., Richard John Lombardy, John J. Clifford, Ying-Duo Gao, Reem M. Haidar, Eugene W. Kelleher, Adel M. Moussa, Yesh P. Sachdeva, Minghua Sun, Heather N. Taft
-
Patent number: 6037378Abstract: Phenylacetic acid derivatives of the formula I ##STR1## where the substituents and the index have the following meanings: X is NOCH.sub.3, CHOCH.sub.3, CHCH.sub.3 ;Y is O, NRR.sup.1,R independently of one another are hydrogen and C.sub.1 -C.sub.4 -alkyl;R.sup.2 is cyano, nitro, trifluoromethyl, halogen, alkyl and alkoxy;m is 0, 1 or 2, it being possible for the radicals R.sup.2 to be different when m is 2;R.sup.3 is hydrogen, cyano, C.sub.1 -C.sub.4 -alkyl, C.sub.1 -C.sub.4 -haloalkyl, C.sub.3 -C.sub.6 -cycloalkyl;R.sup.4, R.sup.5 and R.sup.6 have the meanings given in claim 1,and their salts, a process and intermediates for the preparation of these compounds, and compositions comprising them for controlling animal pests and harmful fungi.Type: GrantFiled: January 14, 1999Date of Patent: March 14, 2000Assignee: BASF AktiengesellschaftInventors: Thomas Grote, Herbert Bayer, Ruth Muller, Hubert Sauter, Reinhard Kirstgen, Volker Harries, Gisela Lorenz, Eberhard Ammermann, Siegfried Strathmann
-
Patent number: 6034138Abstract: The present invention comprises a concentrated solid or semi-solid disinfectant or sterilant composition for use in an aqueous disinfecting or sterilizing solution, comprising an oxidant and a protected glutaraldehyde such as a glutaraldehyde bisulfite addition compound (GBS): ##STR1## or a glutaraldehyde dioxime compound (GDO): ##STR2## The present invention further provides a method for disinfecting or sterilizing a surface or apparatus comprising the steps of mixing a concentrated solid or semi-solid glutaraldehyde sterilant composition comprising an oxidizing compound and a protected sterilant with water to form a solution and bringing the solution into contact with the surface or apparatus.Type: GrantFiled: November 21, 1995Date of Patent: March 7, 2000Assignee: Block Drug Company, Inc.Inventors: Joseph Synodis, Stuart Wilensky, Alan Halecky
-
Patent number: 6013676Abstract: The present invention is directed to a pesticide composition with improved raindrop resistance characterized in that it contains 0.1-70% by weight of a pesticidal component and 10-50% by weight of sorbitan trioleate relative to the weight of the pesticide composition.Type: GrantFiled: February 9, 1998Date of Patent: January 11, 2000Assignee: Nippon Soda Co., Ltd.Inventors: Masahiro Suzuki, Michio Tani, Keiichi Sato
-
Patent number: 6011054Abstract: The present invention relates to a method of treatment of depression in a human being identified as having depression. This method comprises the administration of a therapeutically effective depression treatment amount of N-acetyl-serotonin (NAS), also referred to as N-acetyl-5-hydroxytryptamine, to a human being identified as having depression. The NAS may be administered alone or in combination with other agents, e.g., Ca.sup.++ antagonists.Type: GrantFiled: November 4, 1998Date of Patent: January 4, 2000Assignee: St. Elizabeth's Medical Center of BostonInventors: Gregory F. Oxenkrug, Pura J. Requintina
-
Patent number: 6008257Abstract: Hydroxamic derivatives of the formula (I): ##STR1## in which A represents hydrogen or a grouping which can be readily eliminated;A.sup.1 represents hydrogen or alkyl;Ar represents optionally substituted arylene or heteroarylene;E represents a 1-alkene-1,1-diyl grouping which contains a radical R.sup.1 in the 2-position, or represents a 2-aza-1-alkene-1,1-diyl grouping which contains a radical R.sup.2 in the 2-position, or represents an optionally substituted imino grouping ("azamethylone", N--R.sup.3);G represents a bridge member as defined herein; andZ represents in each case optionally substituted alkyl, alkenyl, alkinyl, cycloalkyl, aryl or heterocyclyl;are useful as fungicides. Also disclosed is a process for preparing the compounds of formula (I).Type: GrantFiled: August 21, 1997Date of Patent: December 28, 1999Assignee: Bayer AktiengesellschaftInventors: Bernd-Wieland Kruger, Lutz Assmann, Herbert Gayer, Peter Gerdes, Ulrich Heinemann, Dietmar Kuhnt, Thomas Seitz, Bernd Gallenkamp, Ralf Tiemann, Gerd Hanssler, Heinz-Wilhelm Dehne, Stefan Dutzmann
-
Patent number: 5993864Abstract: A novel chelate complex allows the formation of stable solutions of molecular chlorine dioxide. The chelate complexes are composed of the electron-deficient chlorine dioxide molecule, which can accept an electron, and a chelating agent, which can contribute its available electrons to the accepting orbital of the chlorine dioxide molecule. Both active and passive methods of releasing the chlorine dioxide from such chelates by competitive displacement with selected metal cations are presented. In this manner a stabilized solution of molecular chlorine dioxide can be stored until needed and the chlorine dioxide released at time of use for cleaning, disinfection or other uses.Type: GrantFiled: July 11, 1997Date of Patent: November 30, 1999Inventor: Robert D. Kross
-
Patent number: 5990161Abstract: Hydroximic acid derivatives, useful as pesticides, have the formula ##STR1## in which G is G.sub.3 or G.sub.4 having the formula: ##STR2## in which R.sub.5 is lower alkyl; R.sub.6 and R.sub.7 are, independently, hydrogen or lower alkyl; W is O, S, SO or SO.sub.2 ; X.sub.1, X.sub.2 and X.sub.3 are, independently, hydrogen or a variety of substituents; and R.sub.1, R.sub.2 and R.sub.3 are, independently, hydrogen or a variety of substituents.Type: GrantFiled: December 30, 1998Date of Patent: November 23, 1999Assignee: Rhone-Poulenc AgrochimieInventors: Yoshie Kirio, Takako Maeda, Norio Sasaki, Norishige Toshima, Nobumitsu Sawai, Bruce Milligan, Joseph Perez, Jean-Pierre Vors, Daniel B. Gant
-
Patent number: 5981549Abstract: Disclosed herein is a method for controlling or alleviating the symptoms of respiratory disease and allergies comprising administering to a mammal suffering from respiratory disease or allergies an effective amount of an acetylcholine esterase reactivator having an oxime moiety optionally in association with an acetylcholine receptor antagonist.Type: GrantFiled: February 14, 1997Date of Patent: November 9, 1999Assignee: Synapse Pharmaceutical InternationalInventor: Norman Viner
-
Patent number: 5977182Abstract: Compounds of formula (I), wherein Y is hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, OH, CN, NO.sub.2, Si(CH.sub.3).sub.3, CF.sub.3 or halogen, and T is a group (a) or (b), and wherein the remaining substituents have the following definitions: X is O, S or NR.sub.13 ; A is O or NR.sub.4 ; R.sub.1 is hydrogen, C.sub.1 -C.sub.4 alkyl, halo-C.sub.1 -C.sub.4 alkyl, cyclopropyl, C.sub.1 -C.sub.4 alkoxymethyl, C.sub.1 -C.sub.4 alkoxy, C.sub.1 -C.sub.4 alkylthio or cyano; R.sub.2 is hydrogen, C.sub.1 -C.sub.6 alkyl, C.sub.3 -C.sub.6 cycloalkyl, cyano unsubstituted or substituted C.sub.1 -C.sub.6 alkoxycarbonyl, unsubstituted or substituted di(C.sub.1 -C.sub.6 alkyl)aminocarbonyl, unsubstituted or substituted C.sub.1 -C.sub.6 alkyl-S(O).sub.q, unsubstituted or substituted aryl-S(O).sub.q, unsubstituted or substituted heteroaryl, unsubstituted or substituted heterocyclyl, unsubstituted or substituted heterocyclylcarbonyl or unsubstituted or substituted phenyl; and R.sub.Type: GrantFiled: May 1, 1997Date of Patent: November 2, 1999Assignee: Novartis Finance CorporationInventors: Rene Zurfluh, Hugo Ziegler, Stephan Trah
-
Patent number: 5955632Abstract: New seco-D steroid derivatives, processes for their preparation and pharmaceutical compositions are provided, which are active on the cardiovascular system.Type: GrantFiled: July 10, 1997Date of Patent: September 21, 1999Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.Inventors: Mauro Gobbini, Sergio De Munari, Giorgio Fedrizzi, Patrizia Ferrari, Piero Melloni, Marco Santagostino, Marco Torri
-
Patent number: 5935999Abstract: A compound of formula (I): ##STR1## wherein A is oxygen, W is CH.sub.3 O.CH.dbd.CCO.sub.2 CH.sub.3 and R.sup.1, R.sup.2, R.sup.3, X, Y and Z are as defined in the specification. The compounds are useful as plant fungicides and insecticides.Type: GrantFiled: July 31, 1995Date of Patent: August 10, 1999Assignee: Zeneca LimitedInventors: Paul Anthony Worthington, Ian Henry Aspinall
-
Patent number: 5929121Abstract: A method for the protection of trees of the families Musaceae or Plantanginaceae from destructive pests whereby the trees to be protected share a common root system.Type: GrantFiled: December 13, 1996Date of Patent: July 27, 1999Assignee: Rhone-Poulenc AgroInventors: Jorge Cepeda, Juan Bocanegra
-
Patent number: 5916903Abstract: A method is provided for alleviating the effects of antineoplastic disease treatment comprising administering to a mammal undergoing such treatment an acetylcholine esterase reactivator or prodrug derivative thereof optionally in association with an acetylcholine receptor antagonist.Type: GrantFiled: February 28, 1997Date of Patent: June 29, 1999Assignee: Synapse Pahrmaceuticals International, Inc.Inventor: Norman Viner
-
Patent number: 5902816Abstract: A method is provided for the treatment of heavy metal poisoning in a mammal comprising administering to a mammal including humans suffering from heavy metal poisoning a heavy metal chelating amount of an oxime.Type: GrantFiled: February 21, 1997Date of Patent: May 11, 1999Assignee: Synapse Pharmaceuticals International, Inc.Inventor: Norman M. Viner
-
Patent number: 5883106Abstract: Novel compounds having the ability to inhibit 5-lipoxygenase enzyme and having the following formula I: ##STR1## and the pharmaceutically acceptable salts thereof, wherein Ar.sup.1 is a heterocyclic moiety which is selected from imidazolyl, pyrrolyl, pyrazolyl, 1,2,3-triazolyl, 1,2,4-triazolyl, indolyl, indazolyl and benzimidazolyl, which is bonded to X.sup.1 through a ring nitrogen atom, and which may be optionally substituted with one or two substituents selected from halo, hydroxy, cyano, amino, and C.sub.1-4 alkyl; X.sup.1 is a direct bond or C.sub.1-4 alkylene; Ar.sup.2 is phenylene optionally substituted with halo, hydroxy, cyano, and amino X.sup.2 is --A--X-- or --X--A-- wherein A is a direct bond or C.sub.1-4 alkylene and X is oxy, thio, sulfinyl or sulfonyl; Ar.sup.3 is phenylene, pyridylene, thienylene, furylene, oxazolylene or thiazolylene optionally substituted with one or two substituents selected from halo, hydroxy, cyano, amino and C.sub.1-4 alkyl; R.sup.1 and R.sup.2 are each C.sub.Type: GrantFiled: February 6, 1998Date of Patent: March 16, 1999Assignee: Pfizer Inc.Inventors: Rodney W. Stevens, Takashi Mano, Kazunari Nakao, Yoshiyuki Okumura
-
Patent number: 5877171Abstract: The method of this invention is directed to a treatment of depression in men and women and to a treatment of pre-menstrual syndrome (PMS) in women by administering to a patient a therapeutically effective amount of chromium in a pharmaceutically acceptable form either alone or in conjunction with the administration of a standard antidepressant composition, such as a selective serotonin reuptake inhibitor composition. Chromium, preferably in the form of chromium picolinate, is administered to the patient at dosages in a preferred range of about 200 to about 500 micrograms chromium.Type: GrantFiled: July 28, 1997Date of Patent: March 2, 1999Inventor: Malcolm N. McLeod
-
Patent number: 5877190Abstract: A compound of formula (I): ##STR1## wherein: R.sub.1 represents unsubstituted or substituted cycloalkyl, phenyl, naphthyl, heterocyclic, alkyl or alkenyl,A represents a bond, oxygen, sulphur, a group ##STR2## a group ##STR3## or a group ##STR4## wherein Rc represents hydrogen, alkyl or cycloalkyl, R.sub.2 represents halogen, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, cycloalkyl, formyl, carboxy, alkylcarbonyl, cycloalkylcarbonyl, alkoxycarbonyl, cycloalkyloxycarbonyl, optionally substituted carbamoyl, optionally substituted amino, formylamino, cyano, optionally substituted amidino, hydroxyaminomethyl, amide oxime, hydrazono, or a group selected from: ##STR5## wherein R.sub.21, R.sub.22 and R.sub.23 are as defined in the description, R.sub.Type: GrantFiled: October 3, 1997Date of Patent: March 2, 1999Assignee: Adir et CompagnieInventors: Alain Dhainaut, Guillaume Poissonnet, Emmanuel Canft, Michel Lonchampt
-
Patent number: 5874467Abstract: The present invention relates to phenylacetic acid derivatives of the formula I ##STR1## and their salts. The invention additionally relates to processes and intermediates for preparing these compounds and compositions containing them for controlling animal pests and harmful fungi.Type: GrantFiled: July 31, 1996Date of Patent: February 23, 1999Inventors: Herbert Bayer, Hubert Sauter, Ruth Muller, Wassilios Grammenos, Albrecht Harreus, Reinhard Kirstgen, Franz Rohl, Eberhard Ammermann, Gisela Lorenz
-
Patent number: 5874476Abstract: Disclosed is a method of inhibiting the growth of microorganisms in, at, or on a locus subject to microbial attack, comprising introducing to said locus an antimicrobially effective amount of at least one dihaloformaldoxime carbamate.Type: GrantFiled: July 14, 1997Date of Patent: February 23, 1999Assignee: Rohm and Haas CompanyInventors: Adam Chi-Tung Hsu, Barry Clifford Lange, Jemin Charles Hsu
-
Patent number: 5869535Abstract: A composition and method of preventing or inhibiting tumor growth, and of treating malignant melanoma, without toxic side effects are disclosed. Betulinic acid or a betulinic acid derivative is the active compound of the composition, which is topically applied to the situs of tumor.Type: GrantFiled: May 16, 1997Date of Patent: February 9, 1999Assignee: The Board of Trustees of the University of IllinoisInventors: John M. Pezzuto, Tapas K. DasGupta, Darrick S. H. L. Kim
-
Patent number: RE36594Abstract: The invention is the use of nitronyl substituted hindered phenols as antioxidants in therapeutic applications. In the preferred embodiment the compositions have the general formula: ##STR1## Wherein R1 is hydrogen, an alkyl or an aryl and R2 is an alkyl or an aryl; R.sub.3 is an alkyl; and R.sub.4 is an alkyl. Further, the invention relates to novel compositions useful as antioxidants. The novel compounds include: 2,6-di-tert-butyl-4-(N-tert-octyl)nitronyl phenol (DBONP); 2,6-dimethyl-4-(N-tert-octyl)nitronyl phenol (DMONP); N-tert-octyl-C-phenyl nitrone (OPN).Type: GrantFiled: October 2, 1997Date of Patent: February 29, 2000Assignee: Oklahoma Medical Research FoundationInventors: Edward G. Janzen, Allan L. Wilcox